It has been reported that LUCAT1 has an antitumour effect by modulating miRNA expression and signalling pathways in clear cell renal cell carcinoma, bladder cancer, colorectal cancer, hepatocellular carcinoma, breast cancer and cervical cancer 27. The gene discussed is LUCAT1; the disease is breast carcinoma.